Sartorius AG

Greenhouse gas emissions & sustainability report data

📊 Latest report period: 2023🗂️ Report periods on file: 2023, 2022, 2017

In its 2023 reporting, Sartorius AG disclosed greenhouse gas emissions of 898.9K t CO2eq. By scope: Scope 1: 13.1K t CO2eq; Scope 2: 26.8K t CO2eq; Scope 3: 857.0K t CO2eq. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
898.9K t CO2eq
2023
⚡
Renewable Energy
35.5%
of total energy
💧
Water Usage
699.6K m3
2023
♻️
Waste
10.0K tons
2023
⚙️
Energy Use
196.4K MWh
2023

📊 Emissions by Scope (2023)

ScopeWhat it coversReported value
Scope 1Direct emissions from sources the company owns or controls (fuel combustion, company vehicles, process and fugitive emissions).13.1K t CO2eq
Scope 2Indirect emissions from purchased electricity, steam, heat and cooling.26.8K t CO2eq
Scope 3Other indirect emissions across the value chain (purchased goods, business travel, use of sold products, etc.).857.0K t CO2eq

New to scopes? Read Scope 1, 2 and 3 emissions explained and market-based vs location-based Scope 2.

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
2023898.9K t CO2eq
20221.1M tCO2e (market-based calculation)
201729.7K t CO2eq

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🎯 Climate & Sustainability Targets

🔜 Short-term

  • Reduce CO2 emissions intensity by an average of around 10 percent per year by 2030.
  • Cut all avoidable direct and indirect emissions from purchased energy to zero by 2030.
  • Obtain 100 percent of its electricity from renewable sources by 2030.
  • Achieve an average annual sales revenue growth in the low-teens percentage range over the five-year period to 2028.

📅 Medium-term

  • Net climate neutral by 2045.

🔭 Long-term

  • Net climate neutral by 2045.

🌱 ESG Focus Areas

ClimateMaterials and circularityWater and wastewaterSocial responsibilityCorporate governanceSustainability in the supply chains

⚠️ Challenges & Risks +

  • Overall expected normalization of demand in the biopharmaceutical market.
  • Geopolitical tensions.
  • Longer than expected reduction in customer inventories.
  • Pronounced market weakness in China.
  • Strong reluctance to invest in the USA.
  • Discontinued business with Russian customers.
  • Muted investment activity overall.

📋 Report Information

Reporting Period: 2023
Frameworks: GRI, Greenhouse Gas Protocol
Assurance: KPMG AG Wirtschaftsprüfungsgesellschaft